Global Gastritis Treatment Market Is Estimated To Witness High Growth Owing To Growing Prevalence Of Gastrointestinal Disorders And Rising Rate Of Drug Approvals And Launches

 

Gastritis Treatment Market

Overview:

If case of Chronic Gastritis, doctors will recommend lifestyle changes to reduce symptoms and help the stomach lining heal. These may include eating smaller meals, avoiding spicy or acidic foods, and not lying down after eating. Drinking plenty of water and avoiding alcohol are also helpful. These medicines neutralize stomach acid and relieve pain. They can be found over the counter, such as famotidine (Pepcid), or prescription, such as lansoprazole (Prevacid) and omeprazole (Prilosec). Steady use of aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) irritate the stomach lining. Some types of cancer treatments can also trigger gastritis, especially chemotherapies that are given by mouth. Excessive alcohol can irritate and erode the stomach lining. Stress also can bring on gastritis. Severe physical trauma, such as a car accident or severe burns, can also cause gastritis.

Market Dynamics:

Rising research and developmental activities are estimated to augment growth of the global Gastritis Treatment Market during the forecast period. For instance, MArinomed Biotech has developed a new drug for treating autoimmune gastritis in October 2020. The company is aiming to focus on the anti-inflammatory treatment instead of treating the deficiency symptoms. Moreover, rising cost of treatments and unavailability of appropriate treatments are anticipated to restrain growth of the global gastritis treatment market during the forecast period.

Impact of COVID-19:

The outbreak was first reported in 2019 and then it was transmitted to all parts of the world. The pandemic had a significant impact on all individuals. However, people suffering from gastrointestinal disorders were severely affected. As the early symptoms of gastrointestinal diseases like diarrhea, abdominal pain, and vomiting, were also witnessed in people suffering from COVID-19. Therefore, diagnosing these symptoms that further led to respiratory problems was a major concern. This led to increase in demand for gastritis treatments during the pandemic. This had a positive impact on the growth of the global gastritis treatment market.

Key Takeaways:

The global Gastritis Treatment Market is expected to witness robust growth, exhibiting CAGR of 3.67 % over the forecast period, due to growing acquisitions. For instance, AstraZeneca acquired CinCor Pharma Inc., in January 2023, for 1.8 Billion. This acquisition will support in accelerating AstraZeneca’s cardio renal and chronic kidney disease treatments. 

North America is anticipated to witness robust growth in the global gastritis treatment market during the forecast period, due to growing prevalence of gastritis and increasing unhealthy lifestyles of the population.

Key players active in the global Gastritis Treatment Market are Zydus Group, F. Hoffmann-La Roche Ltd., Lupin, Mylan N.V., Endo International plc, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd, Sanofi, Amgen Inc., Pfizer Inc., Lilly, GSK plc, Merck & Co., Inc., Novartis AG, Sun Pharmaceutical Industries Ltd., AstraZeneca, and Johnson & Johnson Private Limited.

 

Comments

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

The Global Clinical Laboratory Services Market Is Expected To Reach Around Us$ 381.6 Billion By The End Of 2027

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027